|
Name |
Heptadecane
|
Molecular Formula | C17H36 | |
IUPAC Name* |
heptadecane
|
|
SMILES |
CCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C17H36/c1-3-5-7-9-11-13-15-17-16-14-12-10-8-6-4-2/h3-17H2,1-2H3
|
|
InChIKey |
NDJKXXJCMXVBJW-UHFFFAOYSA-N
|
|
Synonyms |
HEPTADECANE; n-Heptadecane; 629-78-7; Hexadecane, methyl-; Heptadekan; H7C0J39XUM; CHEBI:16148; MFCD00009002; NSC-172782; Heptadecane, analytical standard; EINECS 211-108-4; C17H36; UNII-H7C0J39XUM; NSC 172782; BRN 1738898; AI3-36898; Heptadecane purum; Normal-heptadecane; PJ8; Heptadecane, 99%; DSSTox_CID_27061; DSSTox_RID_82078; DSSTox_GSID_47061; 4-01-00-00548 (Beilstein Handbook Reference); CHEMBL3185332; DTXSID7047061; Samarium(III)ChlorideHexahydrate; HSDB 8347; CH3-[CH2]15-CH3; ZINC8217397; Tox21_302278; LMFA11000003; NSC172782; STL355860; AKOS000487450; Heptadecane, purum, >=98.0% (GC); NCGC00256101-01; AS-56326; CAS-629-78-7; DB-054356; CS-0197341; FT-0626894; H0023; C01816; D97702; Q150888; 43B472DE-3A6B-4855-8457-9D679B0D1C87
|
|
CAS | 629-78-7 | |
PubChem CID | 12398 | |
ChEMBL ID | CHEMBL3185332 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 240.5 | ALogp: | 8.8 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 17 | QED Weighted: | 0.293 |
Caco-2 Permeability: | -4.812 | MDCK Permeability: | 0.00000793 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.302 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.085 | Plasma Protein Binding (PPB): | 98.29% |
Volume Distribution (VD): | 3.961 | Fu: | 1.52% |
CYP1A2-inhibitor: | 0.227 | CYP1A2-substrate: | 0.186 |
CYP2C19-inhibitor: | 0.354 | CYP2C19-substrate: | 0.068 |
CYP2C9-inhibitor: | 0.094 | CYP2C9-substrate: | 0.95 |
CYP2D6-inhibitor: | 0.276 | CYP2D6-substrate: | 0.053 |
CYP3A4-inhibitor: | 0.191 | CYP3A4-substrate: | 0.042 |
Clearance (CL): | 4.492 | Half-life (T1/2): | 0.058 |
hERG Blockers: | 0.248 | Human Hepatotoxicity (H-HT): | 0.007 |
Drug-inuced Liver Injury (DILI): | 0.263 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.031 |
Skin Sensitization: | 0.954 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.936 |
Respiratory Toxicity: | 0.488 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000400 | 0.942 | D07ILQ | 0.627 | ||||
ENC000379 | 0.939 | D00AOJ | 0.611 | ||||
ENC000428 | 0.891 | D0Z5SM | 0.585 | ||||
ENC000423 | 0.878 | D00FGR | 0.570 | ||||
ENC000285 | 0.845 | D05ATI | 0.500 | ||||
ENC000422 | 0.816 | D0O1PH | 0.456 | ||||
ENC000082 | 0.815 | D0T9TJ | 0.413 | ||||
ENC000380 | 0.815 | D00MLW | 0.385 | ||||
ENC000430 | 0.803 | D00STJ | 0.370 | ||||
ENC000488 | 0.776 | D05QNO | 0.366 |